Segall Bryant & Hamill’s 908 Devices MASS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-217,221
Closed -$4.47M 735
2022
Q2
$4.47M Buy
217,221
+64,586
+42% +$1.09M 0.05% 334
2022
Q1
$2.9M Buy
152,635
+360
+0.2% +$6.19K 0.03% 400
2021
Q4
$3.94M Buy
152,275
+74,296
+95% +$2.19M 0.04% 348
2021
Q3
$2.54M Buy
+77,979
New +$2.65M 0.02% 435

Other funds holding MASS

Segall Bryant & Hamill's MASS Position: Q3 2022 in Review

Segall Bryant & Hamill sold out of 908 Devices (MASS) in Q3 2022, closing a stake of 217,221 shares — an estimated $4.47M sold.

Segall Bryant & Hamill first reported a position in MASS in Q3 2021 and held it in 4 quarters. The position peaked at $4.47M in Q2 2022. 81 funds tracked by Wall St. Rank hold MASS as of Q3 2022.

  • Segall Bryant & Hamill reported no remaining 908 Devices position as of Q3 2022 after selling out during the quarter.
  • Segall Bryant & Hamill sold 217,221 908 Devices shares in Q3 2022, an estimated $4.47M.
  • Segall Bryant & Hamill first reported a position in 908 Devices in Q3 2021 and held it in 4 quarters.
  • Segall Bryant & Hamill's 908 Devices position peaked at $4.47M in Q2 2022.
  • 81 funds tracked by Wall St. Rank held 908 Devices as of Q3 2022.

Based on Segall Bryant & Hamill's 13F filing for Q3 2022, filed 14 Nov 2022.